In support of our data some of the differentially expressed genes represented in our progression-associated candidate set (COL10A1, COL11A1, MMP11, SULF1, and THBS2) have also been identified in another study comparing gene expression of matched DCIS/IBC pairs [14]. This evidence concerns the gene COL11A1 and ductal breast carcinoma in situ.